News | October 05, 2010

VEITHsymposium to Highlight Vascular Disease Research, Clinical Findings


October 5, 2010 - The 37th annual VEITHsymposium, for vascular disease specialists, will be held Nov. 17 – 21 at the Hilton New York. The five-day event will feature more than 450 rapid-fire presentations from world-renowned vascular specialists with emphasis on the latest advances, changing concepts in diagnosis and management, pressing controversies, and new techniques.

The extended length and format allows the program to cover the diseases, conditions, diagnostic procedures, and medical interventions that comprise the landscape for vascular medicine. That includes treatment and management of patients with diseases of the veins and arteries, such as aneurysms, vessel blockage, traumatic lesions, thromboembolism, ischemia, stroke, peripheral arterial disease (PAD), carotid stenosis, and varicose veins. The conference also will deal with wound care, vascular access and other treatments of vascular problems or diseases approachable via the vascular system.

Additionally, the CREST Trial, which purported to show that stenting was equally effective as the more conventional surgical endarterectomy for treating carotid atherosclerosis and preventing stroke, is expected to draw attention at the symposium.

For more information: www.veithsymposium.org


Related Content

Feature | Cath Lab | Kyle Hardner

Since receiving FDA approval in 2016, intravascular lithotripsy (IVL) systems have grown in popularity among ...

Home November 14, 2025
Home
News | Cath Lab

Nov. 11, 2025 — FastWave Medical has successfully completed enrollment in its 30-patient coronary feasibility study and ...

Home November 13, 2025
Home
News | Cath Lab

Oct. 28, 2025 — Results from the first-of-its-kind randomized PROCTOR trial found that a strategy of saphenous vein ...

Home November 04, 2025
Home
News | Cath Lab

Oct. 27, 2025 — Results from the PREVUE-VALVE study suggest that there are currently at least 4.7 million people aged 65 ...

Home October 29, 2025
Home
News | Cath Lab

Oct. 25, 2025 — Medtronic plc has announced the launch of the Stedi Extra Support guidewire, designed to enhance ...

Home October 28, 2025
Home
News | Cath Lab

Oct. 27, 2025 — Elixir Medical, a developer of technologies to treat cardiovascular disease, has announced new clinical ...

Home October 28, 2025
Home
News | Cath Lab

Oct. 22, 2025 — Heartflow, Inc. has introduced Heartflow PCI Navigator, the newest addition to the Heartflow One ...

Home October 23, 2025
Home
News | Cath Lab

Oct. 15, 2025 — Stereotaxis recently announced it has obtained CE Mark in Europe and submitted a 510(k) application to ...

Home October 16, 2025
Home
News | Cath Lab

Oct. 7, 2025 — Medtronic has announced the full distribution of the Neuroguard IEP System (Neuroguard) after a ...

Home October 07, 2025
Home
News | Cath Lab

Sept. 22, 2025 — Nicklaus Children's Heart Institute in Miami, Florida, is now offering bedside transcatheter patent ...

Home September 23, 2025
Home
Subscribe Now